Detailed information for compound 1816743

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 246.267 | Formula: C15H10N4
  • H donors: 0 H acceptors: 3 LogP: 2.2 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: N#Cc1cccc(c1)n1ccc(n1)c1cccnc1
  • InChi: 1S/C15H10N4/c16-10-12-3-1-5-14(9-12)19-8-6-15(18-19)13-4-2-7-17-11-13/h1-9,11H
  • InChiKey: FWIRAYALBWXCDD-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0347 1 1
Loa Loa (eye worm) hypothetical protein 0.0039 0.0644 0.0644
Trypanosoma brucei PAB1-binding protein , putative 0.0029 0.0332 0.5
Leishmania major hypothetical protein, conserved 0.0029 0.0332 0.5
Brugia malayi hypothetical protein 0.0029 0.0332 0.2768
Loa Loa (eye worm) hypothetical protein 0.0029 0.0332 0.0332
Loa Loa (eye worm) inward rectifying k channel family protein 1 0.0347 1 1
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0058 0.1199 0.1199
Trypanosoma cruzi PAB1-binding protein , putative 0.0029 0.0332 0.5
Loa Loa (eye worm) hypothetical protein 0.0058 0.1199 0.1199
Brugia malayi Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog 0.0037 0.0569 0.4745
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0035 0.0495 0.5
Plasmodium vivax ataxin-2 like protein, putative 0.0029 0.0332 0.5
Brugia malayi latrophilin 2 splice variant baaae 0.0039 0.0644 0.5371
Trypanosoma cruzi PAB1-binding protein , putative 0.0029 0.0332 0.5
Loa Loa (eye worm) voltage and ligand gated potassium channel 0.0037 0.0569 0.0569
Schistosoma mansoni voltage-gated potassium channel 0.004 0.0672 1
Echinococcus granulosus potassium voltage gated channel subfamily H 0.0037 0.0569 1
Schistosoma mansoni voltage-gated potassium channel 0.004 0.0672 1
Schistosoma mansoni hypothetical protein 0.0039 0.0644 0.9581
Plasmodium falciparum ataxin-2 like protein, putative 0.0029 0.0332 0.5
Plasmodium falciparum ataxin-2 like protein, putative 0.0029 0.0332 0.5
Echinococcus multilocularis potassium voltage gated channel subfamily H 0.0037 0.0569 1
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0035 0.0495 0.5
Toxoplasma gondii hypothetical protein 0.0347 1 1
Brugia malayi Calcitonin receptor-like protein seb-1 0.0058 0.1199 1
Loa Loa (eye worm) hypothetical protein 0.0032 0.042 0.042
Loa Loa (eye worm) hypothetical protein 0.0347 1 1
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0058 0.1199 1
Brugia malayi hypothetical protein 0.0019 0.0018 0.0147

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.